Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Thyroid Cancer Surgery Complications Higher Than Predicted

By HospiMedica International staff writers
Posted on 31 May 2017
Thyroid cancer surgery complication rates are greater than predicted, and patients who are older, with more comorbidities, and with advanced disease are at greatest risk, according to a new study.

Researchers at University of Michigan conducted a study of 27,912 patients that underwent surgery for differentiated or medullary thyroid cancer between 1998 and 2011. More...
Using data from the Surveillance, Epidemiology, and End Results (SEER) Medicare database, the researchers evaluated general complications that occurred within 30 days of surgery, and thyroid surgery specific complications within one year of surgery.

The results showed that 6.5% of the patients developed general post-operative complications, which included fever, infection, hematoma, cardiopulmonary, and thromboembolic events; 12.3% developed thyroid surgery specific complications, including hypoparathyroidism, hypocalcemia, and vocal cord and fold paralysis. Complication rates were significantly higher in patients 65 years of age and older, patients with more advanced thyroid cancer, and patients with other co-existing medical conditions. The study was published on April 28, 2017, in the Journal of Clinical Endocrinology and Metabolism.

“Even in low-risk patients, the risk of vocal cord paralysis is still 2% and the risk of hypoparathyroidism is 8%. This is higher than we'd like to see,” said senior author Megan Haymart, MD. “When we work with patients to treat thyroid cancer, we're always balancing benefits and risks. This study shows there are more complications from surgery for thyroid cancer than expected. It suggests an opportunity to educate both patients and providers to decrease complications and improve outcomes.”

“That 12% of patients overall had thyroid surgery specific complications is concerning; most of our surgeons quote a one to three percent rate. This is quadruple what we had thought,” added lead author Maria Papaleontiou, MD. “Thyroidectomy is considered a fairly safe operation in general, but some populations are more vulnerable. Advanced disease was associated with the highest number of complications; 23% of patients whose cancer had spread throughout the body had thyroid surgery specific complications.”


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.